Internal Draft   Train the trainer materials are based on draft labeling under review at FDA. Promotional materials will be revised following FDA approval.     An invitation to a community of support and inspiration     www.copaxone.com       SHARED SOLUTIONS® INVITES YOU TO A SPECIAL EVENT     Program Name: Mar 28, 4:00 PM-6:00 PM   lipsum naratif con Teva Forum 2800 Bishop Drive San Ramon, CA 94523-2800   This program is by invitation only. A single guest, 18 years of age or older, may attend the program with you.     Be connected. Be inspired. Be informed. This is your opportunity to share your experiences and insights, discover resources, and exchange ideas with other people in your community who have been touched by relapsing MS—all without traveling far from home.   If you have any questions, please do not hesitate to call Shared Solutions® at 1-800-887-8100.         COPAXONE® is indicated for the treatment of patients with relapsing forms of multiple sclerosis.   Important Safety Information   Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.   Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.   Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.   A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.   The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.   You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.   Please see full Prescribing Information.           Privacy Notice | One Click Unsubscribe | Terms of Use             COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered service mark of Teva Neuroscience, Inc. © 2014 Teva Neuroscience, Inc. COP-42322 Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall Avenue, Overland Park, KS 66211